Answer
Interstitial pneumonia/pneumonitis and interstitial lung disease, sometimes fatal, have been reported with cabazitaxel at an unknown frequency that cannot be estimated from available data; pneumonia and pulmonary embolism have also been reported.
Sources for this answer
- Cabazitaxel 60 mg Concentrate and Solvent For Solution For InfusionDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.8 Undesirable effects · Version 5Document updated
Sources checked